🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer (BARCODE1) out on NEJM nejm.org/doi/full/10.10… Study evaluated a targeted #ProstateCancer screening approach using polygenic risk scores derived from 130 known genetic variants, identifying men aged 55–69 in

🚨 ESMO’s New Global Guidelines for Molecular Tumor Boards (MTBs) 🧬💻 Published in Annals of Oncology, this comprehensive special article by Ben Westphalen et al. and the ESMO - Eur. Oncology Precision Oncology Working Group delivers international recommendations to standardize MTB

It was very sad to learn that M Schneider passed away. Maurice created ESMO - Eur. Oncology in 1975 together with G Mathe, in Ville de Nice 50 years later, ESMO - Eur. Oncology includes almost 45k members around the 🌍, trains all generations of doctors and transforms practice of oncology w its frameworks

Attending #AACR25? Meet Timothy A. Yap, the new Editor-in-Chief of Clinical Cancer Research, at 2:00 PM CT on Monday, April 28 at the AACR Publications Booth 2615. brnw.ch/21wS9vQ Clinical Cancer Research

Check out this great paper on the impact of CHIP in cancer in NEJM - work led by Oriol Pich and the extended Charles Swanton team!

Now the incredible Mariam Jamal-Hanjani presenting data from the TRACERx Peace cohorts defining the metastatic cascade in Nsclc ⁦Science and Innovation at Cancer Research UK⁩ ⁦UCL Cancer Institute⁩ ⁦The Crick⁩

Happy to share our latest work published in Annals of Oncology: 🚫 Lack of ctDNA clearance during neoadj IO may identify patients unlikely to achieve pCR. ⚠️ ctDNA clearance has limited confirmatory power due to low specificity and high heterogeneity. Thanks to all coauthors!

🔬 #AACR25 | ElenaGarralda, Director of the #UITM CaixaResearch VHIO, has chaired the session “Bispecifics: The Case of Duality”, where she has also presented: “Expanding the potential of bispecific antibodies: Beyond T-cell engagers.” Innovation in motion at the AACR Annual

🗞️ Published in Cell Reports Medicine: SALSA, a new artificial intelligence tool developed by Radiomics Group for the automated and precise analysis of liver tumors. ➡️ linke.to/SALSAVHIO #RadiomicsVHIO

👉 MAP 2025 Scientific Co-Chairs Mariam Jamal-Hanjani, Lisa Derosa, and Joaquin Mateo highlight why your abstract matters — ⏰submit by 10 June and be part of the Molecular Analysis for Precision Oncology Congress 2025 in Paris. #MAP2025 🔗 ow.ly/uvh250VNq6L

💬 Raquel Perez-Lopez Radiomics Group presents “Radiomics: Where Are We in Clinical Cancer Practice?” at the 3rd #AIforOncology Congress — highlighting the power of imaging and AI in cancer diagnosis and treatment. EU Interdisc. Society of AI for Cancer Research

📣Save the date and prepare your abstracts. More details to follow

You still have 3+ weeks to submit your abstract to ESMO - Eur. Oncology #MAP2025 - cancer biology, precision medicine and beyond - join us in Paris in Sept **Abstract submission deadline 10 June**

📣 New VHIO-CaixaResearch Scientific Seminar‼️ 🔹 Lung cancer metastatic dissemination from the perspective of the cancer cell, its microenvironment, and the host 👩‍🔬 Mariam Jamal-Hanjani, UCL Cancer Institute 🗓 Friday, 23rd May, at 12h Hosted by: Joaquin Mateo Register at 👉

📣 New VHIO-CaixaResearch Scientific Seminar‼️ 🔹 Lung cancer metastatic dissemination from the perspective of the cancer cell, its microenvironment, and the host 👩‍🔬 Mariam Jamal-Hanjani, UCL Cancer Institute 🗓 Friday, 23rd May, at 12h Hosted by: Joaquin Mateo Register at 👉

Ganadora de la I Beca FERO - Carmen Mateu para médicos investigadores Enhorabuena Dra. Raquel Perez-Lopez Perelada Vall d’Hebron Institute of Oncology (VHIO) #cancerdeprostata #vhio #becasFERO

👏🔬 Laura Soucek ha recibido el #PremiCiutatBCN en Ciencias de la Vida del Ajuntament de Barcelona por su estudio sobre #MYC como diana terapéutica en tumores sólidos, publicado en Nature Medicine. ¡Enhorabuena por este gran reconocimiento‼️ 👉 linke.to/LauraSoucekCiu…

Getting ready for ASCO #ASCO25? ✈️🔬 There’s lots of theranostics … including a dedicated session for prostate cancer. Don’t miss these! 👀

🔴 First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer. These data were presented today at #ASCO25 by Elena Élez and published in NEJM 👉 linke.to/BreakwaterASCO… ASCO Scott Kopetz

PEACE-3 trial is out! Addition of Radium-223 to enza prolonged rPFS by 3 months in 1L mCRPC. Final OS pending annalsofoncology.org/article/S0923-….